Ingevity's reaffirmation of its FY24 sales forecast suggests stability and confidence in its business outlook, closely aligning with market expectations. This reiteration may reassure investors about the company's future performance, potentially stabilizing its stock price in the short term. However, since the forecast is in line with expectations, the immediate impact on the stock price might be neutral, as the market has likely already priced in this information.